Liver-Directed Therapies for Hepatic Metastases

Flavio E. Baio; Barrett C. Riddle; Mark A. Sultenfuss; Nestor F. Esnaola

doi:10.1007/978-3-030-78117-0_14

Liver-Directed Therapies for Hepatic Metastases

Flavio E. Baio, Barrett C. Riddle, Mark A. Sultenfuss, Nestor F. Esnaola

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Uveal melanoma has in the liver the most common site of metastases. Although there is no clear consensus about the management of metastatic uveal melanoma, therapy directed specifically toward secondary liver lesions has been associated with notable clinical utility. In this chapter, we present an overview of the different treatment options that have been evaluated with and supported by sound scientific bases, from surgical approaches to interventional radiology options. Specific indications, limitations, and outcomes of each need to be kept in mind to offer the most appropriate patient-centered care.

Original language	English (US)
Title of host publication	Uveal Melanoma
Subtitle of host publication	Biology and Management
Publisher	Springer International Publishing
Pages	193-202
Number of pages	10
ISBN (Electronic)	9783030781170
ISBN (Print)	9783030781163
DOIs	https://doi.org/10.1007/978-3-030-78117-0_14
State	Published - Jan 1 2021

Keywords

Hepatic metastases
Liver-directed therapy
Metastatic uveal melanoma
Surgical resection
Uveal melanoma

ASJC Scopus subject areas

Medicine(all)
Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.1007/978-3-030-78117-0_14

Cite this

@inbook{88379535deb54b3b8b3859ee06ce4d9f,

title = "Liver-Directed Therapies for Hepatic Metastases",

abstract = "Uveal melanoma has in the liver the most common site of metastases. Although there is no clear consensus about the management of metastatic uveal melanoma, therapy directed specifically toward secondary liver lesions has been associated with notable clinical utility. In this chapter, we present an overview of the different treatment options that have been evaluated with and supported by sound scientific bases, from surgical approaches to interventional radiology options. Specific indications, limitations, and outcomes of each need to be kept in mind to offer the most appropriate patient-centered care.",

keywords = "Hepatic metastases, Liver-directed therapy, Metastatic uveal melanoma, Surgical resection, Uveal melanoma",

author = "Baio, {Flavio E.} and Riddle, {Barrett C.} and Sultenfuss, {Mark A.} and Esnaola, {Nestor F.}",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2021.",

year = "2021",

month = jan,

day = "1",

doi = "10.1007/978-3-030-78117-0_14",

language = "English (US)",

isbn = "9783030781163",

pages = "193--202",

booktitle = "Uveal Melanoma",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Liver-Directed Therapies for Hepatic Metastases

AU - Baio, Flavio E.

AU - Riddle, Barrett C.

AU - Sultenfuss, Mark A.

AU - Esnaola, Nestor F.

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2021.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Uveal melanoma has in the liver the most common site of metastases. Although there is no clear consensus about the management of metastatic uveal melanoma, therapy directed specifically toward secondary liver lesions has been associated with notable clinical utility. In this chapter, we present an overview of the different treatment options that have been evaluated with and supported by sound scientific bases, from surgical approaches to interventional radiology options. Specific indications, limitations, and outcomes of each need to be kept in mind to offer the most appropriate patient-centered care.

AB - Uveal melanoma has in the liver the most common site of metastases. Although there is no clear consensus about the management of metastatic uveal melanoma, therapy directed specifically toward secondary liver lesions has been associated with notable clinical utility. In this chapter, we present an overview of the different treatment options that have been evaluated with and supported by sound scientific bases, from surgical approaches to interventional radiology options. Specific indications, limitations, and outcomes of each need to be kept in mind to offer the most appropriate patient-centered care.

KW - Hepatic metastases

KW - Liver-directed therapy

KW - Metastatic uveal melanoma

KW - Surgical resection

KW - Uveal melanoma

UR - http://www.scopus.com/inward/record.url?scp=85160477232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85160477232&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-78117-0_14

DO - 10.1007/978-3-030-78117-0_14

M3 - Chapter

AN - SCOPUS:85160477232

SN - 9783030781163

SP - 193

EP - 202

BT - Uveal Melanoma

PB - Springer International Publishing

ER -

Liver-Directed Therapies for Hepatic Metastases

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this